Legislation watch
Mackinac Center for Public Policy
Capitol Building

2007 Senate Bill 926: Restrict anticonvulsant drug interchange

facebook  twitter    Comments on this legislation    Post new comment    Text and Analysis    Add to Watch List 
  Previous   Next 

Most Recent Comments

1) Do Your Homework  by Anonymous Citizen on October 6, 2008 
This is not about the difference between name brand and generic medications. Some epilepsy patients do better on a generic, while others do better on a name brand prescription. Switching medications (regardless of whether the switch is from name brand to generic, generic to name brand, generic to generic or name brand to name brand) can be extremely dangerous for a person with epilepsy. Switching medications exposes those with epilepsy to an unnecessary risk and an increased chance for a breakthrough seizure. It can take years for a doctor to determine the correct medication dosage and brand for a patient, and switching that medication poses a very dangerous risk. Do your homework, pharmacy student. There is no logical reason for this legislation to not be passed (unless you're too lazy to call the physician, that is).
Reply

Line

2) but that would be  by Anonymous Citizen on April 21, 2008 
giving the doctor and the patient FREEDOM OF CHOICE, which every liberal knows is abhorant to the DEMOCRAT WAY.


Reply

Line

3) BAD IDEA!!!  by Anonymous Citizen on April 21, 2008 
I've looked into this and can't seem to find any actual clinical studies that have shown generics of antiepileptics to be any less effective than the brand name. On the contrary, I've found quite a few trials that show no difference in efficacy.

Furthermore, if a doctor preferred a patient to have brand name, he/she need do no more than write "DAW" on the prescription. If a patient preferred brand, he/she need do no more than ask for it.

-Pharmacy Student
Reply

Line


View Full Conversation